Stock Warrant
WARRANTSAB Biotherapeutics, Inc. Warrant
No redemption notice detected. Our weekly 8-K watcher runs every Friday and stamps this card if the issuer files a redemption 8-K.
SABSW is SAB Biotherapeutics, Inc. Warrant (Healthcare) — a non-dividend-paying stock. Trading at $0.03. Capital Quality Rank: 49/100 — Stagnant mediocrity.
Stock snapshot
| Price | $0.03 |
| Market cap | — |
| Sector | Healthcare |
| Exchange | XNAS |
| Pays dividend | No |
Capital Quality & fundamentals
DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.
| Capital Quality Rank (1-100) | 49 / 100 · Stagnant mediocrity |
| ROIC (TTM) | -8.0% |
| Shareholder buyback yield | 0.00% |
| Altman Z-score zone | Distress |
About SABSW
SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders. The company's lead product candidate, SAB-142, targets autoimmune Type 1 Diabetes (T1D) with a disease-modifying therapeutic approach that aims to change the T1D treatment paradigm by delaying onset and potentially preventing disease progression of Stage 3 T1D patients. It is focused on developing product candidates for disease targets where a differentiated approach has the greatest potential to be either first-in-class against novel targets against complex targets to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders.
Related non-dividend companies
Other non-dividend stocks investors research alongside SABSW. Peer set from Massive news + returns similarity, filtered to names we currently track.
Frequently asked
What is SABSW's current stock price?
SABSW (SAB Biotherapeutics, Inc. Warrant) is currently trading at $0.03.
Does SABSW pay a dividend?
SABSW (SAB Biotherapeutics, Inc. Warrant) does not currently pay a regular dividend.
What is SABSW's Capital Quality Rank?
SABSW has a Capital Quality Rank of 49/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.
Track SABSW in DiviDrip
Add SABSW to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.
- Open DiviDrip — search SABSW and add it to your watchlist.
- Stock Screener — filter by sector, market cap, and Capital Quality Rank.
- How to use the Screener — sector / quality / market-cap filters explained.
Data refreshed 2026-08-30. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.